APH the world turns
All eyes were on $APHA Friday, as the best soap opera in the pot world arrived at the much-anticipated culmination of its latest high-drama plot arc, and payed it off in epic fashion.
Articles by Braden Maccke
The war for retail cannabis shelf space: January 2019 edition
$APHA is still at the top of the product mix, with $WEED close behind. Some big moves this month, including the rise of $TLRY retail and a new launch from $OGI.
Namaste Technologies cancelled my favorite show
In a Boxing Day video message to his subscribers, Namaste Technologies $N CEO Sean Dollinger told the Namaste faithful that he was no longer going to be doing Namaste 420, the weekly web address and talk show that they tuned in to religiously, effectively cancelling the best show in small cap.
The skinny on Green Growth Brands – should Leamington Be Aphraid?
This $GGB bid for $APHA scans like a stunt. But if they stick the landing, and everyone’s still watching, why stop the show?
The Weed Stock Ecosystem in 2019
Despite a full-on collapse in equity markets on both sides of the border, hope springs eternal in the still-young marijuana business.
Is Namaste’s innovation premium running thin?
Namaste’s superpower is being able to get across to the retail crowd better than any of their peers. Tragically, they don’t know how to use it.
Beat (of) the Market Dec 17 /18
FA traded by appointment too, until last Wednesday when they did 2 million shares out of nowhere. The volume carried on throughout the week, and continued on today, when they had done 1 million shares at close. This pulse came suddenly, on no news.
Aphria changes lawyers while Liberty Health runs interference
It was a slow day over at The Midas Letter. With nothing new from Aphria (TSX:APHA)(NYSE:APHA) about how wrong the short reports are, James West […]
The APHologists
Following Hindenburg Research’s allegation that Aphria (TSX:APHA)(NYSE:APHA)’s acquisition of Latin American and Caribbean assets this past summer was less than kosher, The Bank of Nova […]
GRAPHRIA: Hindenburg Smacks APHA. Marijuana Datajam picks up the pieces
The only ones shocked by Hindenburg Research’s revelations last week that Aphria (TSX:APHA)(NYSE:APHA) was spending shareholder money on assets whose value they inflated all by […]